Professor Kevin Pfleger is a leader in drug discovery and biomedical innovation, whose work has advanced technologies used to identify and test potential medicines. He co-invented a Dimerix treatment for a rare kidney disease that has progressed to Phase 3 clinical trials and co-founded RAGE Biotech to develop treatments for chronic inflammatory disease. He has combined academic research with entrepreneurship for more than 25 years. As Director of Biomedical and Health Innovation at the WA Life Sciences Innovation Hub and Chair of Perth Biodesign and Biodesign Australia, he supports researchers and entrepreneurs developing new treatments and technologies.